|
Evidence Based Laboratory Medicine and Test Utilization
Citations 331-340 of 441 total displayed.
|
Past content
(since Jan 1997):
|
- Enzymes and Protein Markers
Increased concentrations of genotype-interpreted Ca 19-9 in urine of bladder cancer patients mark diffuse atypia of the urothelium
- Else Marie Vestergaard, Hans Wolf, and Torben F. Ørntoft
Clin. Chem. 1998; 44: 197-204.
[Abstract]
[Full text]
[PDF]
- Endocrinology and Metabolism
Direct enzyme immunometric measurement of plasma big endothelin-1 concentrations and correlation with indicators of left ventricular function
- Cornelia Haug, Wolfgang Koenig, Martin Hoeher, Matthias Kochs, Vinzenz Hombach, Adolf Gruenert, and Hans Osterhues
Clin. Chem. 1998; 44: 239-243.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Assessment of simple colorimetric procedures to determine smoking status of diabetic subjects
- Robert F. Smith, Hugh M. Mather, and Gordon A. Ellard
Clin. Chem. 1998; 44: 275-280.
[Abstract]
[Full text]
[PDF]
- Test Utilization and Outcome
Multivariate discrimination for phenylketonuria (PKU) and non-PKU hyperphenylalaninemia after analysis of newborns' dried blood-spot specimens for six amino acids by ion-exchange chromatography
- Andrew A. Reilly, Ronald Bellisario, and Kenneth A. Pass
Clin. Chem. 1998; 44: 317-326.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Effect of Plasma Replacement Therapy on Determinations of Urine Protein Concentration
- Clara Peña, Cecília Martínez-Brú, Rosa Homs, Teresa Planella, and Mariano Cortés
Clin. Chem. 1998; 44: 359-360.
[Extract]
[Full text]
[PDF]
- TDM Conference
Total testing process applied to therapeutic drug monitoring: impact on patients' outcomes and economics
- Gerald E. Schumacher and Judith T. Barr
Clin. Chem. 1998; 44: 370-374.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Analytical goals in therapeutic drug monitoring
- Larry D. Bowers
Clin. Chem. 1998; 44: 375-380.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Prospective investigations of concentration–clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring
- Leslie M. Shaw, Bruce Kaplan, and Kenneth L. Brayman
Clin. Chem. 1998; 44: 381-387.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Strategies for physician education in therapeutic drug monitoring
- David W. Bates, Steven J. Soldin, Petrie M. Rainey, and Joseph N. Micelli
Clin. Chem. 1998; 44: 401-407.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies
- Lutz Binder, Xaver Schiel, Claudia Binder, Cristina Fernandes Almeida Menke, Silke Schüttrumpf, Victor W. Armstrong, Michael Unterhalt, Norbert Erichsen, Wolfgang Hiddemann, and Michael Oellerich
Clin. Chem. 1998; 44: 408-414.
[Abstract]
[Full text]
[PDF]
|
|
